Cargando…
Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy
BACKGROUND: Leprosy remains a health problem in many countries, with difficulties in diagnosis resulting in delayed treatment and more severe disabilities. Antibodies against several Mycobacterium leprae antigens have, however, shown value as diagnostic and/or prognostic markers. OBJECTIVES: The obj...
Autores principales: | Marçal, Pedro Henrique Ferreira, Fraga, Lúcia Alves de Oliveira, de Mattos, Ana Márcia Menezes, Menegati, Laura, Coelho, Angélica da Conceição Oliveira, Pinheiro, Roberta Olmo, Sarno, Euzenir Nunes, Duthie, Malcolm S, Teixeira, Henrique Couto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851060/ https://www.ncbi.nlm.nih.gov/pubmed/29513821 http://dx.doi.org/10.1590/0074-02760170467 |
Ejemplares similares
-
Identifying Leprosy and Those at Risk of Developing Leprosy by Detection of Antibodies against LID-1 and LID-NDO
por: Amorim, Francianne M., et al.
Publicado: (2016) -
Evaluation of antibody detection against the NDO-BSA, LID-1 and NDO-LID antigens as confirmatory tests to support the diagnosis of leprosy in Yunnan province, southwest China
por: Jian, Liu, et al.
Publicado: (2020) -
Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil
por: Leturiondo, André Luiz, et al.
Publicado: (2019) -
Leprosy: prevalence and factors associated with seropositivity for anti-NDO-LID antibodies in children under 15 years of age
por: Gomes, Luciane Cardoso, et al.
Publicado: (2019) -
Multibacillary leprosy patients with high and persistent serum antibodies
to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2
reactions
por: Mizoguti, Danielle de Freitas, et al.
Publicado: (2015)